Brief: AN2 Therapeutics Q1 Operating Expenses USD 11.537 Million
13/05/2025 21:03
May 13 (Reuters) - AN2 Therapeutics Inc ANTX.O: AN2 THERAPEUTICS Q1 OPERATING EXPENSES USD 11.537 MILLION AN2 THERAPEUTICS Q1 INCOME FROM OPERATIONS USD -11.537 MILLION AN2 THERAPEUTICS Q1 NET INCOME USD -10.649 MILLION AN2 THERAPEUTICS Q1 EPS USD -0.35 Source text: ID:nBw3MWKQ5a Further company coverage: ANTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview